» Articles » PMID: 3569410

In Vitro Binding of the Very Potent and Selective D-2 Dopamine Agonist, [3H]N-0437 to Calf Caudate Membranes

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 1987 Feb 10
PMID 3569410
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

N-0437, a non-catecholic aminotetralin has recently been described as a very potent and selective dopamine D-2 agonist. In this study the in vitro binding of [3H]N-0437 (specific activity 80.6 Ci/mmol) to calf caudate membranes is described. It was found that [3H]N-0437 binds with a high affinity (KD = 0.17 nM) and a low proportion of non-specific binding. Moreover the binding was saturable with a high number of binding sites (Bmax = 703 +/- 28 fmol/mg protein) and reversible (dissociation half-time = 68 min). Pharmacological analysis of [3H]N-0437 binding showed that it was selective for dopamine receptors and that it was also stereoselective for D-2 receptors. Non-dopaminergic drugs were without exception very poor displacers. Taken together the results suggest that [3H]N-0437 labels dopamine D-2 receptors with a high selectivity in the calf brain, and thus, that it should be a useful tool in studies of central dopamine receptors.

Citing Articles

Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors.

Wood M, Dubois V, Scheller D, Gillard M Br J Pharmacol. 2014; 172(4):1124-35.

PMID: 25339241 PMC: 4314200. DOI: 10.1111/bph.12988.


The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.

Scheller D, Ullmer C, Berkels R, Gwarek M, Lubbert H Naunyn Schmiedebergs Arch Pharmacol. 2008; 379(1):73-86.

PMID: 18704368 DOI: 10.1007/s00210-008-0341-4.


Development of a radioreceptor assay for the D2-selective dopamine agonist N-0437.

Ensing K, Bloemhof D, In t Hout W, van der Lende J, de Zeeuw R Pharm Res. 1988; 5(5):283-7.

PMID: 2907622 DOI: 10.1023/a:1015922619831.


Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.

Mulder T, DE VRIES J, Dijkstra D, Wiechers J, Grol C, Horn A Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(5):494-501.

PMID: 2830544 DOI: 10.1007/BF00169305.


Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques.

Arnt J, Hyttel J J Neural Transm Gen Sect. 1990; 80(1):33-50.

PMID: 2137705 DOI: 10.1007/BF01245021.